Subscribe to the InfoTech eNewsletter

infoTECH News

TMCNet:  Arrowhead to Present at Upcoming Investor Conferences

[June 10, 2014]

Arrowhead to Present at Upcoming Investor Conferences

PASADENA, Calif. --(Business Wire)--

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it will present at two upcoming investor conferences.

Scheduled presentations include the following:

Wells Fargo (News - Alert) 2014 Healthcare Conference - Boston

June 17, 2014 - At 1:45 p.m. EDT Christopher Anzalone, Ph.D., President and Chief Executive Officer, will deliver a corporate presentation, and at 2:20 p.m. EDT he will participate in the "Gene Manipulation" panel discussion

Piper Jaffray GenomeRx Symposium - New York

June 23, 2014 - At 3:30 p.m. EDT David Lewis, Ph.D., Chief Scientific Officer, will participate in the "RNA/DNA: Getting It Where You NeedIt" panel discussion

About Arrowhead Research Corporation

Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead's pipeline includes clinical programs in chronic hepatitis B virus and partner-based programs in obesity and oncology.

For more information please visit, or follow us on Twitter (News - Alert) @ArrowRes. To be added to the Company's email list to receive news directly, please send an email to

[ InfoTech Spotlight's Homepage ]

blog comments powered by Disqus


Subscribe to InfoTECH Spotlight eNews

InfoTECH Spotlight eNews delivers the latest news impacting technology in the IT industry each week. Sign up to receive FREE breaking news today!
FREE eNewsletter

infoTECH Whitepapers